Intriguingly, the targeted removal of the ATXN3 gene led to a noteworthy decrease in the protein expression of Galectin-9 (Fig. 1, A and B), a carbohydrate-binding protein known for modulating immune response, inhibiting tumor cell growth, and inducing apoptosis (20). Here, ATXN3 is linked to neoplasm.